Last reviewed · How we verify
NCT04792424
No Monitoring of Post-filter Ionized Calcium in Regional Citrate Anticoagulation
NA trial testing Regional citrate anticoagulation in Regional Citrate Anticoagulation in 50 participants. Completed in 15 June 2022.
30 May 2022
Quick facts
| Lead sponsor | Chulalongkorn University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 50 |
| Start date | 1 April 2021 |
| Primary completion | 30 May 2022 |
| Estimated completion | 15 June 2022 |
| Sites | 1 location across Thailand |
Drugs / interventions tested
- Regional citrate anticoagulation — full drug profile →
- Vasopressor — full drug profile →
- Antibiotic — full drug profile →
- Dialysis with continuous renal replacement therapy
Conditions studied
- Regional Citrate Anticoagulation — all drugs for Regional Citrate Anticoagulation →
- Ionized Calcium — all drugs for Ionized Calcium →
- Continuous Renal Replacement Therapy — all drugs for Continuous Renal Replacement Therapy →
Sponsor
Chulalongkorn University
Who can join
18 and older, any sex, with Regional Citrate Anticoagulation or Ionized Calcium. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Do no monitor of post-circuit ionized calcium affact the filter life time of continueous renal replacement therapy with regional citrate anticoagulation circuit? A randomized control trial
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Standard versus no post-filter ionized calcium monitoring in regional citrate anticoagulation for continuous renal replacement therapy (NPC trial).
Thanapongsatorn P, Sinjira T, Kaewdoungtien P, Kusirisin P, et al · · 2023 · cited 4× · PMID 37664560 · DOI 10.1093/ckj/sfad069
Verify or expand the search:
- PubMed search for NCT04792424
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Regional citrate anticoagulation
Trials testing the same drug.
- NCT04865510 — Citrate Versus Heparin in Continuous Renal Replacement Therapy : · NA · completed
- NCT03791190 — RCA for CRRT in Liver Failure and High Risk Bleeding Patients · NA · unknown
- NCT06646328 — Oxidative Stress and Circulating Nuclear DNA (cfDNA) in Acute Kidney Injury and Continuous Renal Replacement Therapies. · Phase 4 · terminated
Other recruiting trials for Regional Citrate Anticoagulation
Currently open trials in the same condition.
- NCT06021080 — Effects of Different Continuous Renal Replacement Therapy Patterns on Ionized Calcium in Patients With Citrate Anticoagu · recruiting
Other Chulalongkorn University trials
Trials by the same sponsor.
- NCT07458659 — Clinical Study of BCMA-Targeted CAR T-Cell Injection in the Treatment of Patients With Relapsed/Refractory Multiple Myel · EARLY_PHASE1 · not yet recruiting
- NCT07346118 — Fluid Balance Guided by Modified Venous Excess Ultrasonography Versus Standard Care in Patients With Acute Kidney Injury · NA · not yet recruiting
- NCT07388862 — Comparison of Treatment Outcome of Pulpotomy With Versus Without Dental Operating Microscope in Carious Mature Permanent · EARLY_PHASE1 · not yet recruiting
- NCT07373977 — Comparison of Postoperative Pain After Pulpotomy Performed With Versus Without Dental Operating Microscope in Carious Ma · EARLY_PHASE1 · not yet recruiting
- NCT07078929 — Clinical Trial of CMD63 Chimeric Antigen Receptor T-cell (CAR T-cell) in Children With Acute Lymphoblastic Leukemia (ALL · Phase 1 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04792424 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Chulalongkorn University
- Last refreshed: 14 November 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04792424.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing